Cdc4βプロペラルのブレードにリン酸化Cdk阻害剤をウビキチン化する
1Programs in Chemical Biology and Cancer Biology and Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, CA 94305, USA.
Cell
|January 30, 2003
まとめ
リン酸化は,SCF-Cdc4ユビキチンリガゼの基板結合を調節する. 新しい結晶構造は,Cdc4がリン酸化基板に結合する方法を明らかにし,単一のサイトでの規制メカニズムを説明しています.
科学分野:
- バイオケミストリー バイオケミストリー
- 分子生物学は分子生物学である.
- 構造生物学 構造生物学とは
背景:
- SCF-Cdc4ユビキチンリガゼ複合体は,細胞循環の調節とタンパク質の分解において重要な役割を果たします.
- リン酸化イベントは,SCF-Cdc4.の活性と基板特異性を調節することが知られている.
- 基板認識の正確な分子機構を理解することは,細胞信号伝達経路の解読に不可欠です.
研究 の 目的:
- SCF-Cdc4ユビキチンリガゼのCdc4サブユニットによる基板結合の構造的基礎を解明する.
- リン酸化がCdc4とその高親和性基板との相互作用をどのように調節するかを調査する.
- 複数の調節性リン酸化が単一の結合部位で調整されるメカニズムについての洞察を提供するためです.
主な方法:
- Cdc4サブユニットの構造を決定するために,X線結晶学を用いた.
- Cdc4は,高親和性の基質フォスホペプチドと複合的に結晶化されました.
- 結合インタフェースと相互作用を特徴付けるために,構造分析が行われました.
主要な成果:
- 高親和性フォスホペプチド基板に結合したCdc4の結晶構造が決定されました.
- Cdc4とリン酸化基板の間の特定の結合相互作用に関する詳細な洞察が得られました.
- この発見は,単一の結合部位が複数のリン酸化イベントに対応し,制御される仕組みを示唆している.
結論:
- 決定された構造は,SCF-Cdc4がリン酸化基質を認識する方法の分子理解を提供します.
- この研究は,リン酸化によるユビキチンリガース活性調節の正確なメカニズムを明らかにしています.
- この発見は,細胞サイクル制御とタンパク質のターンオーバー経路の理解に意味を持ちます.
関連する概念動画
01:45Positive Regulator Molecules
To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
00:50Anaphase Promoting Complex
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...